|
Dr. Kalani is Board Certified in Cardiology, Internal Medicine as well as Certified Cardiac Device Specialist. He is a Fellow of American College of Cardiology (FACC) and Recipient of Certification from International Board of Heart Rhythm Examiners (CCDS). He is Fellowship trained in the field of Cardiovascular Medicine and underwent his fellowship training at Coney Island Hospital and Maimonides Medical Center in Brooklyn, NY after completing his Internal Medicine Residency there. He served as the Chief Resident during his Internal Medicine residency and engaged in teaching medical students and Residents. While at Coney Island Hospital, he served as a part-time Emergency Medicine Sessions physician as well. After completing the Fellowship training, he decided to move and settle in Florida and chose Pinellas county as his residence to provide for good schooling environment for his children. He has been in practice in Tarpon Springs, Florida since 1996. His clinical interests include cardiac and vascular disease diagnosis and management, anticoagulation (Coumadin clinic) management, Lipid management (lipid clinic), non-invasive cardiovascular studies, Nuclear Cardiology including Stress testing, Echocardiography including Trans-Esophageal Echocardiography, Vascular studies (PAD and Venous disease evaluation and treatment, tilt table testing, Holter and Event Recorder studies for evaluation of heart rhythm disorders, diagnostic cardiac catheterizations via the Radial (wrist) and Femoral (groin) approaches, Cardiac device implants and management of pacemakers and Defibrillators, varicose vein treatment by Laser and Radiofrequency ablation.
|
Continuing Medical Education: 
Use of an adherent skin barrier drape was associated with a significant decrease in hospitalization for cardiac implantable electronic device (CIED) infection, according to a study in Heart Rhythm O2.
Patients with increased systolic blood pressure in midlife are at increased risk for atrial fibrillation in mid-to-late life.
Medicare will now cover weight loss drug semaglutide if taken for heart benefits.
FDA announces new recall impacting more than 66,000 Impella heart pumps after 49 deaths
